Stryker Corporation (SYK)
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical
SYK inks an agreement to acquire Inari Medical at a valuation of approximately $4.9 billion.
Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Inari Medical (NARI) stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker (SYK) proved to be true.
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
On Monday, Stryker Corporation SYK agreed to acquire Inari Medical Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion.
Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal
Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news.
Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources say
Medical-device maker Stryker is in advanced talks to acquire Inari Medical , which makes devices that treat patients with venous diseases, people familiar with the matter told Reuters on Monday.
Here's Why You Should Retain Stryker Stock in Your Portfolio for Now
SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
Stryker Gains 30.2% Year to Date: What's Driving the Stock?
SYK continues to witness growth on the back of a robust product line and strategic acquisitions.
Stryker Stock May Gain From Oculan Lighting Platform's Launch
SYK launches the Oculan Lighting Platform to improve lighting conditions in the operating rooms and allow surgeons to perform with more accuracy.
Stryker Bringing in Big Money
Strong financial performance has investors eyeing Stryker Corporation (SYK) closely.
SYK Stock Rises Following the Launch of Next Generation SurgiCount+
Stryker launches the next generation of SurgiCount+ to boost sponge management and blood loss assessment in hospitals.
Stryker Stock Gains on Q3 Earnings Beat & Raised Guidance
SYK's third-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript
Stryker Corporation. (NYSE:SYK ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Finance and Investor Relations Glenn Boehnlein - Vice President, Chief Financial Officer Conference Call Participants Robert Marcus - JPMorgan Lawrence Biegelsen - Wells Fargo Securities Joanne Wuensch - Citi Ryan Zimmerman - BTIG Travis Steed - Bank of America Matthew O'Brien - Piper Sandler Companies Vijay Kumar - Evercore ISI Matthew Miksic - Barclays Steven Litchman - Oppenheimer & Co David Roman - Goldman Sachs Christopher Pasquale - Nephron Research Jason Wittes - Roth MKM Michael Matson - Needham & Company Danielle Antalffy - UBS Equities Richard Newitter - Truist Securities Matthew Taylor - Jefferies Jeffrey Johnson - Robert W.
